C(N(CC)C(C)C)(C)C.[Cl:10][C:11]1[CH:12]=[C:13]([N:18]2[C:22]([C:23]3[CH:24]=[N:25][CH:26]=[C:27]([F:29])[CH:28]=3)=[CH:21][C:20]([C:30]([OH:32])=O)=[N:19]2)[CH:14]=[CH:15][C:16]=1[F:17].Cl.[NH:34]1[CH:38]=[CH:37][NH:36][C:35]1=O.C1CN([P+]([O:56]N2N=NC3C=CC=CC2=3)(N2CCCC2)N2CCCC2)CC1.F[P-](F)(F)(F)(F)F>C1COCC1>[Cl:10][C:11]1[CH:12]=[C:13]([N:18]2[C:22]([C:23]3[CH:24]=[N:25][CH:26]=[C:27]([F:29])[CH:28]=3)=[CH:21][C:20]([C:30]([N:34]3[CH2:38][C:37](=[O:56])[NH:36][CH2:35]3)=[O:32])=[N:19]2)[CH:14]=[CH:15][C:16]=1[F:17]0.16 ml (0.89 mmol) of N,N-diisopropylethylamine is added to a solution of 100 mg (0.30 mmol) of the compound of Example 60A, 40 mg (0.33 mmol) of 4-imidazolinone-hydrochloride, and 217 mg (0.42 mmol) of PYBOP in 2 ml of THF, and the mixture that is obtained is stirred for 16 hours at room temperature. The reaction mixture is concentrated by evaporation in a vacuum. The residue is diluted with acetonitrile, filtered over a Millipore spray filter, and separated by means of preparative HPLC (mobile solvent: acetonitrile/water gradient). Solvent is removed from the product-containing fractions in a rotary evaporator, and the residue is recrystallized from acetonitrile. 96 mg (80% of theory) of the title compound is obtained.